FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma
FDA批准摘要:恩福妥单抗联合帕博利珠单抗治疗局部晚期或转移性尿路上皮癌
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1393
Brave, Michael H; Maguire, William F; Weinstock, Chana; Zhang, Hui; Gao, Xin; Li, Fang; Yu, Jingyu; Fu, Wentao; Zhao, Hong; Pierce, William F; Chang, Elaine; Dinin, Jeannette; Fiero, Mallorie H; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Amiri-Kordestani, Laleh; Suzman, Daniel L